Initial clinical investigation of Neuron Plus has demonstrated its ability to improve memory, improve response time, improve clarity of thought and improve the general wellbeing of people with AD.
We have used the ‘Clock Test’ to measure at baseline, 1 month, 3 months and 6 months the change in cognitive function and memory. Experts in this field of research agree that this test can be a very effective technique in assessing the comprehension and cognitive function of people suffering from certain types of dementia, and improvement or deterioration over time.
Below is a sample of one of the ‘Clock Tests’ from one of the patients in our study. The diagram on the left depicts an attempt at drawing the time “11:10” at baseline, prior to Neuron Plus being administered, and the one on the right after 1 month of taking Neuron Plus. This particular patient has continued to show improvement for six months.
Based on these initial results, we are designing a protocol for a registered clinical study with a medical institution. We feel a responsibility to share these initial findings with Neuron Plus to people with AD, their carers, friends and families. If you would like more information about the product, or would like to know about our clinical study or have any comments, please click here to contact us.
If you are a healthcare professional wishing to learn more about Foster Health’s clinical studies, we would be grateful to hear from you... please click here to contact us.